For example, inhibiting LDHA or lactate transporters in combination with anti-CTLA-4 therapy leads to increased infiltration of cytotoxic T cells and reduced regulatory T cells, thereby improving anti-tumor immune responses. The gene discussed is CTLA4; the disease is neoplasm.